INOVIO Reports Third Quarter 2023 Financial Results and Operational Highlights
PLYMOUTH MEETING, Pa., Nov. 9, 2023 /PRNewswire/ — INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced its financial results and operational highlights for the third quarter ended September 30, 2023.
Related news for (INO)
- Don’t Miss Out: MoBot’s Latest Stock Updates 08/27/25 04:00 PM
- MoBot alert highlights: NASDAQ: SSKN, NASDAQ: INO, NASDAQ: RMTI, NASDAQ: INHD, NASDAQ: WHLR (08/27/25 03:00 PM)
- HF Sinclair Corporation Announces Pricing of Senior Notes Offering
- HF Sinclair Announces Cash Tender Offer for Debt Securities
- Core Gaming Aggressively Expanding Its AI Innovation in Gaming and Mobile Applications